ACTC Advanced Cell Technology Inc.

[Rat Fink]

ACTC Advanced Cell Technology Inc YTD Price performance Vs its pers



87.0M+427.3%







GERN (http://www.onlinetradersforum.com/research/common/symbolRedirect.asp?symbol=US;GERN) Geron Corporation




666.1M+60.2%







GENZ (http://www.onlinetradersforum.com/research/common/symbolRedirect.asp?symbol=US;GENZ) Genzyme Corporation
14.7B

-18.0%

STEM (http://www.onlinetradersforum.com/research/common/symbolRedirect.asp?symbol=US;STEM) StemCells, Inc.




163.1M+16.2%







ASTM (http://www.onlinetradersforum.com/research/common/symbolRedirect.asp?symbol=US;ASTM) Aastrom

In Phase II trials to develope treatment for heat Desease and other Cardio problems......Figures Thats the #1 killer of us. Where the real bucks lie.
Out of all of these Genzyme GENZ is the one that will be bought out next and should be in your 401K. JMHO
ACTC is a penny play for the next year. Good one to test your skills on trading for free shares.

[Rat Fink]

This would be a great get in point @ .10
Been watching and MM are working thier way to .15
They want it to go up, but the buyers are just not there. A few 1/2M sales got nabbed up, but just didn't have the steam to keep it up past .0175
I hope it goes below .15 I'll be buying as goes down. I think it will go back up from there.
Anyove?

[Rat Fink]

Nice little march up from .15 with very low volume. My guess they'll let it sneak up and then dump as many shares as they can to keep it intresting.
Cardio drugs, and
"Through their efforts ACT is on track to file an IND with the Food and Drug Administrationhttp://images.intellitxt.com/ast/adTypes/2.gif (http://si.advfn.com/p.php?pid=nmona&cb=1248352611&article=38711352&symbol=NO%5EACTC#) for its retinal pigment epithelium cell therapeutic program for the treatment of diseases of the eye the second half of this year.”
So they are going after Macular degeneration and those pesky subretinal neovascularations. Its only the leading cause of blindness in the World or maybe Diabetes is #1. forgot. Great potential.
not in yet.